Organigram Global Inc

Organigram Global Inc(OGI)股票分析

$0.930

-0.034 (-3.65%)收盤時

Loading chart…
最高
0.980
開盤
0.980
成交量加權均價
0.93
成交量
1.66M
市值
164.80M
最低
0.890
成交金額
1.55M
企業價值/稅息折舊攤銷前利潤(TTM)
3.03

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.

AI 分析 of Organigram Global Inc (OGI)

買進

OrganiGram Holdings Inc is a good buy right now due to its recent strong performance, with a current price of 0.9651 and a significant gross margin of 23.06% in Q3 2026. The stock has shown a 5-day change of +2.78% and a projected trajectory indicating a potential increase of +105.64% based on historical patterns. However, investors should be cautious of the risk posed by a high forward P/E ratio of 14.66, which may indicate overvaluation if growth does not materialize as expected.

估值指標

Organigram Global Inc(OGI)目前預期本益比為 15.02,5 年平均預期本益比為 1.47。

預期本益比

合理
5 年均值 P/E
1.47
目前P/E
15.02
高估
49.92
低估
-46.97

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-34.26
目前EV/EBITDA
3.03
高估
201.70
低估
-270.23

預期股價營收比

低估
5 年均值 P/S
1.59
目前P/S
0.30
高估
2.78
低估
0.39

Alphio AI 對 OGI 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%OGI

$1.86

情境價格

基

基準

基準 · 50%OGI

$1.64

情境價格

悲

悲觀

悲觀 · 25%OGI

$1.37

情境價格

事件時間軸

2026-11-03 (ET)

16:30:00

Apple Warns of Margin Drop, Mixed Day for Markets

12:00:00

Apple Warns of Margin Drop, Markets Mixed

09:30:00

Organigram to Acquire Aurora at C$7.80 per Share, Valuing Transaction at Approximately C$561 Million

09:30:00

Organigram to Acquire Aurora Cannabis for C$7.80 per Share

08:30:00

Organigram Holdings Trading Halted, News Pending

資訊

OGI 常見問題 —— 由 Alphio AI 解答

Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).

OrganiGram Holdings Inc is a good buy right now due to its recent strong performance, with a current price of 0.9651 and a significant gross margin of 23.06% in Q3 2026. The stock has shown a 5-day change of +2.78% and a projected trajectory indicating a potential increase of +105.64% based on historical patterns. However, investors should be cautious of the risk posed by a high forward P/E ratio of 14.66, which may indicate overvaluation if growth does not materialize as expected.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易